# Observational Multiple Myeloma studies: 137 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 137 trials that are observational for Multiple Myeloma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Multiple Myeloma studies: 137 rows for $6.85, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/multiple-myeloma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 137
- Recruiting or not yet: 137
- Read on: November 19, 2026

## Trials

The 25 newest of 137, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07927023 | A Study to Learn About a Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma | Pfizer | Observational | Not yet recruiting | Multiple Myeloma | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927023) |
| October 30, 2026 | NCT07906418 | BCMA Polymorphisms in Patients With Multiple Myeloma | Başakşehir Çam & Sakura City Hospital | Observational | Not yet recruiting | Multiple Myeloma | 420 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906418) |
| October 23, 2026 | NCT07891871 | RE-RITE: Real-world Evaluation of Response, Implementation and Toxicity of Elranatamab | The Royal Wolverhampton Hospitals NHS Trust | Observational | Not yet recruiting | Myeloma Multiple | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891871) |
| October 2, 2026 | NCT07855718 | Serum Soluble BCMA as a Non-Invasive Marker in Multiple Myeloma | Assiut University | Observational | Not yet recruiting | Multiple Myeloma | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855718) |
| October 1, 2026 | NCT07851493 | Exercise Phenotyping Prior to Chemotherapy in Newly Diagnosed Multiple Myeloma (MM-Exercise) | Technical University of Munich | Observational | Recruiting | Exercise Behavior, Multiple Myeloma | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851493) |
| September 30, 2026 | NCT07850284 | SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders | Mayo Clinic | Observational | Recruiting | AL Amyloidosis, Multiple Myeloma | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850284) |
| September 17, 2026 | NCT07823959 | CBC-Based Inflammatory Indices in Newly Diagnosed Multiple Myeloma | Assiut University | Observational | Not yet recruiting | Multiple Myeloma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07823959) |
| August 25, 2026 | NCT07785505 | Musculoskeletal Ultrasound in Patients With Hematologic Malignancies | Assiut University | Observational | Not yet recruiting | Hematologic Neoplasms, Leukemia, Lymphoma, Multiple Myeloma, Musculoskeletal Diseases | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07785505) |
| August 20, 2026 | NCT07777406 | Real-life Study on the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma | Università degli Studi 'G. d'Annunzio' Chieti e Pescara | Observational | Recruiting | Plasma Cell Neoplasms | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777406) |
| August 13, 2026 | NCT07763054 | Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | Observational | Recruiting | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Lymphoma, Multiple Myeloma, Chronic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763054) |
| August 4, 2026 | NCT07746232 | Validating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study" | Fondazione EMN Italy Onlus | Observational | Not yet recruiting | Multiple Myeloma (MM) | 92 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746232) |
| July 31, 2026 | NCT07740317 | Neurocognitive Trajectories After BCMA CAR-T | Wake Forest University Health Sciences | Observational | Recruiting | Multiple Myeloma (MM), CART Therapy, Refractory Multiple Myeloma (RRMM) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07740317) |
| July 20, 2026 | NCT07713511 | INfections in Patients Treated With CAR-T | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Not yet recruiting | Relapsed Multiple Myeloma, Refractory Multiple Myeloma, B-Cell Non-Hodgkin Lymphoma, Bloodstream Infections, CAR-T Cell... | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07713511) |
| July 8, 2026 | NCT07691034 | Monitoring MRD in Multiple Myeloma in Serum by Mass Spectrometry | Odense University Hospital | Observational | Not yet recruiting | Multiple Myeloma, Minimal Residual Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691034) |
| July 6, 2026 | NCT07684274 | Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics | The First Affiliated Hospital with Nanjing Medical University | Observational | Not yet recruiting | Multiple Myeloma (MM), Smoldering Multiple Myeloma (SMM), MGUS | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07684274) |
| June 24, 2026 | NCT07665307 | Delayed Toxicities Post-CAR-T | Icahn School of Medicine at Mount Sinai | Observational | Recruiting | Multiple Myeloma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07665307) |
| June 23, 2026 | NCT07663253 | Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients | Shanghai Zhongshan Hospital | Observational | Recruiting | Multiple Myeloma | 333 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07663253) |
| June 8, 2026 | NCT07634263 | Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study | Odense University Hospital | Observational | Not yet recruiting | Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Multiple Myeloma Progression, Multiple... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07634263) |
| May 27, 2026 | NCT07609576 | Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies. | Infanta Leonor University Hospital | Observational | Recruiting | Lymphoma Neoplasms, Myeloma Multiple, Severe Infection, CMV Reactivation, Biespecific Treatment, Biespecific | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07609576) |
| May 12, 2026 | NCT07582354 | MMAPPIN' Study: Multiple Myeloma Analysis For Patient-specific Insights to Dissect Disease Heterogeneity | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Myeloma Multiple | 520 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07582354) |
| May 4, 2026 | NCT07564128 | Infection Surveillance of R/R Multiple Myeloma Patients Treated With Elranatamab as Clinical Practice in Italy | Gruppo Italiano Malattie EMatologiche dell'Adulto | Observational | Not yet recruiting | Multiple Mieloma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07564128) |
| April 30, 2026 | NCT07559799 | A Non-interventional Study of Melphalan Flufenamide (Melflufen) (Pepaxti®) and Dexamethasone in Patients With Relapsed and/or Refractory... | iOMEDICO AG | Observational | Recruiting | Multiple Myeloma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07559799) |
| April 30, 2026 | NCT07558057 | Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study | Aarhus University Hospital | Observational | Not yet recruiting | Malignant Lymphoma - Lymphoplasmacytic, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma | 225 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07558057) |
| April 7, 2026 | NCT07514052 | Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study | Shanxi Bethune Hospital | Observational | Recruiting | Multiple Myeloma of Bone | 127 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07514052) |
| March 27, 2026 | NCT07497165 | Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma | Shanxi Bethune Hospital | Observational | Recruiting | Relapsed/Refractory Multiple Myeloma (RRMM), Multiple Myeloma | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07497165) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 5 |
| Zhujiang Hospital | 4 |
| Wake Forest University Health Sciences | 4 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 4 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 3 |
| UNC Lineberger Comprehensive Cancer Center | 3 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Assiut University | 3 |
| National Cancer Institute (NCI) | 3 |
| M.D. Anderson Cancer Center | 3 |
| CARsgen Therapeutics Co., Ltd. | 2 |
| Mayo Clinic | 2 |
| Shanghai Zhongshan Hospital | 2 |
| Azienda USL Reggio Emilia - IRCCS | 2 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 2 |
| The Royal Wolverhampton Hospitals NHS Trust | 2 |
| BIWAKO | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 2 |
| Fondazione EMN Italy Onlus | 2 |
| Odense University Hospital | 2 |
| [iOMEDICO AG](https://specstream.ai/data/clinical-trials/company/iomedico-ag) | 2 |
| University Hospital, Toulouse | 2 |
| Shanxi Bethune Hospital | 2 |
| Peking University First Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 42 |
| Italy | 21 |
| China | 20 |
| France | 14 |
| Germany | 8 |
| Spain | 5 |
| Canada | 4 |
| Greece | 4 |
| Norway | 3 |
| Switzerland | 3 |
| United Kingdom | 3 |
| Denmark | 3 |
| Czechia | 3 |
| Sweden | 3 |
| South Korea | 2 |
| Turkey (Türkiye) | 2 |
| Belgium | 2 |
| Israel | 2 |
| Austria | 2 |
| Ireland | 2 |
| Japan | 1 |
| Argentina | 1 |
| Poland | 1 |
| Romania | 1 |
| Lithuania | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Vegetarian restaurants in the United States](https://specstream.ai/data/businesses/vegetarian-restaurants/united-states)
- [Oncology practices in the United States](https://specstream.ai/data/businesses/oncology-practices/united-states)
- [Fabric wholesalers in the United States](https://specstream.ai/data/businesses/fabric-wholesalers/united-states)
- [B2B advertising and marketing companies in the United States](https://specstream.ai/data/businesses/b2b-advertising-and-marketing-companies/united-states)
- [Pulmonology practices in the United States](https://specstream.ai/data/businesses/pulmonology-practices/united-states)
- [Hotels in the United States](https://specstream.ai/data/businesses/hotels/united-states)
